Personalized medicine – also referred to as individualized or precision medicine – is a field of research which aims to map out genomes or genetic markers of individual patients to develop personalized drug therapy and treatment interventions.
With so many predictions and promises being made in this much-talked about area of pharma and medicine, Dr Nicola Davies questions whether we truly are entering a new era of personalized medicine.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze